Similar articles

• Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.

  Pagani L, Scarabelli M, Cereda PM, Debiaggi M. Pagani L, et al. Microbiologica. 1987 Jan;10(1):103-10. Microbiologica. 1987. PMID: 3106759
• Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).

  Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C. Dubois V, et al. J Antimicrob Chemother. 2008 Aug;62(2):316-23. doi: 10.1093/jac/dkn174. Epub 2008 May 8. J Antimicrob Chemother. 2008. PMID: 18467306
• Efficacy of antimicrobial drug combinations against Pseudomonas aeruginosa: beta-lactams and aminoglycosides.

  Martinetto P, Malcangi A, Penna R. Martinetto P, et al. G Ital Chemioter. 1988 Jan-Dec;35(1-3):17-21. G Ital Chemioter. 1988. PMID: 3151486 No abstract available.
• [Mechanisms of resistance in Pseudomonas aeruginosa].

  Cercenado Mansilla E, García Garrote F. Cercenado Mansilla E, et al. Rev Clin Esp. 1998 Sep;198 Suppl 2:10-6. Rev Clin Esp. 1998. PMID: 9844472 Review. Spanish. No abstract available.
• [Enterococcal resistance to beta-lactam and aminoglycoside antibiotics].

  Liñares Louzao J, Ayats Ardite J, Alonso Figueres T. Liñares Louzao J, et al. Rev Clin Esp. 1995 Oct;195 Suppl 4:16-21. Rev Clin Esp. 1995. PMID: 9441311 Review. Spanish. No abstract available.